Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
1.650
-0.150 (-8.33%)
At close: Dec 20, 2024, 4:00 PM
1.730
+0.080 (4.85%)
After-hours: Dec 20, 2024, 7:44 PM EST

Adagio Medical Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022
Period Ending
Sep '24 Dec '23 Dec '22
Revenue
0.540.30.19
Revenue Growth (YoY)
187.30%58.73%-
Cost of Revenue
2.131.310.88
Gross Profit
-1.59-1.01-0.69
Selling, General & Admin
19.2811.545.37
Research & Development
10.5815.417.86
Operating Expenses
29.8526.9423.23
Operating Income
-31.44-27.94-23.91
Interest Expense
-2.83-1.66-0.14
Interest & Investment Income
0.1700.04
Other Non Operating Income (Expenses)
7.81-6.990.34
Pretax Income
-26.29-36.59-23.67
Net Income
-26.29-36.59-23.67
Net Income to Common
-7.54-36.59-23.67
Shares Outstanding (Basic)
311
Shares Outstanding (Diluted)
311
Shares Change (YoY)
305.73%1.10%-
EPS (Basic)
-2.47-48.16-31.50
EPS (Diluted)
-2.47-48.16-31.50
Free Cash Flow
-30.41-25.99-22.9
Free Cash Flow Per Share
-9.97-34.20-30.47
Operating Margin
-5789.69%-9314.00%-12652.38%
Profit Margin
-1388.03%-12196.67%-12525.40%
Free Cash Flow Margin
-5599.45%-8661.67%-12118.52%
EBITDA
-30.34-27.41-23.42
D&A For EBITDA
1.10.530.5
EBIT
-31.44-27.94-23.91
Source: S&P Capital IQ. Standard template. Financial Sources.